DE69727312D1 - 4-aryl-3-hydroxychinolin-2-on-derivate als modulatoren des ionenkanals - Google Patents

4-aryl-3-hydroxychinolin-2-on-derivate als modulatoren des ionenkanals

Info

Publication number
DE69727312D1
DE69727312D1 DE69727312T DE69727312T DE69727312D1 DE 69727312 D1 DE69727312 D1 DE 69727312D1 DE 69727312 T DE69727312 T DE 69727312T DE 69727312 T DE69727312 T DE 69727312T DE 69727312 D1 DE69727312 D1 DE 69727312D1
Authority
DE
Germany
Prior art keywords
hydroxychinolin
modulators
aryl
derivatives
ion channel
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69727312T
Other languages
English (en)
Other versions
DE69727312T2 (de
Inventor
Sing-Yuen Sit
A Meanwell
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bristol Myers Squibb Co
Original Assignee
Bristol Myers Squibb Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bristol Myers Squibb Co filed Critical Bristol Myers Squibb Co
Application granted granted Critical
Publication of DE69727312D1 publication Critical patent/DE69727312D1/de
Publication of DE69727312T2 publication Critical patent/DE69727312T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/20—Oxygen atoms
    • C07D215/22—Oxygen atoms attached in position 2 or 4
    • C07D215/227—Oxygen atoms attached in position 2 or 4 only one oxygen atom which is attached in position 2
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A61P21/02—Muscle relaxants, e.g. for tetanus or cramps
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/06—Antimigraine agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Pain & Pain Management (AREA)
  • Pulmonology (AREA)
  • Vascular Medicine (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Urology & Nephrology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DE1997627312 1996-11-26 1997-11-18 4-aryl-3-hydroxychinolin-2-on-derivate als modulatoren des ionenkanals Expired - Fee Related DE69727312T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US3110596P 1996-11-26 1996-11-26
US31105P 1996-11-26
PCT/US1997/021136 WO1998023273A1 (en) 1996-11-26 1997-11-18 4-aryl-3-hydroxyquinolin-2-one derivatives as ion channel modulators

Publications (2)

Publication Number Publication Date
DE69727312D1 true DE69727312D1 (de) 2004-02-26
DE69727312T2 DE69727312T2 (de) 2004-11-18

Family

ID=21857682

Family Applications (1)

Application Number Title Priority Date Filing Date
DE1997627312 Expired - Fee Related DE69727312T2 (de) 1996-11-26 1997-11-18 4-aryl-3-hydroxychinolin-2-on-derivate als modulatoren des ionenkanals

Country Status (11)

Country Link
US (2) US5892045A (de)
EP (1) EP0942723B1 (de)
JP (1) JP2002508740A (de)
AR (1) AR010306A1 (de)
AT (1) ATE258054T1 (de)
CA (1) CA2266605A1 (de)
DE (1) DE69727312T2 (de)
ES (1) ES2214644T3 (de)
TW (1) TW504504B (de)
WO (1) WO1998023273A1 (de)
ZA (1) ZA9710561B (de)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2341318A (en) * 1998-09-14 2000-03-15 Boehringer Ingelheim Pharma A Dihydroisoquinoline (LOE 908) and Traumatic Brain Injury.
RU2240998C2 (ru) * 1998-12-04 2004-11-27 Бристол-Маерс Сквибб Компани Производные 3-замещенного 4-арилхинолин-2-она в качестве модуляторов калиевых каналов
GB9915414D0 (en) * 1999-07-01 1999-09-01 Glaxo Group Ltd Medical use
TW562799B (en) 1999-12-01 2003-11-21 Bristol Myers Squibb Co Preparation of 3-substituted-4-arylquinolin-2-one derivatives
US7018979B1 (en) 2000-01-26 2006-03-28 Cedars-Sinai Medical Center Method for using potassium channel agonists for delivering a medicant to an abnormal brain region and/or a malignant tumor
US20050153940A1 (en) * 2000-01-26 2005-07-14 Cedars-Sinai Medical Center Method for using potassium channel activation for delivering a medicant to an abnormal brain region and/or a malignant tumor
JP2004511457A (ja) * 2000-10-13 2004-04-15 ブリストル−マイヤーズ　スクイブ　カンパニー 高い細胞内カルシウム濃度の条件下で機能する選択的マキシ−ｋカリウムチャネル・オープナー、その方法および用途
US7211561B2 (en) * 2001-10-12 2007-05-01 Cedars-Sinai Medical Center Method for inducing selective cell death of malignant cells by activation of calcium-activated potassium channels (KCa)
GB0212971D0 (en) * 2002-06-06 2002-07-17 Karobio Ab Novel compounds
US6939968B2 (en) 2002-12-23 2005-09-06 Bristol-Myers Squibb Company Atropisomers of 3-substituted-4-arylquinolin-2-one derivatives
US7179920B2 (en) * 2003-10-14 2007-02-20 Bristol-Myers Squibb Company 3-thia-4-arylquinolin-2-one derivatives
US7132542B2 (en) 2003-10-14 2006-11-07 Bristol-Myers Squibb Company Compounds for the treatment of male erectile dysfunction
US7049309B2 (en) * 2003-10-14 2006-05-23 Bristol-Myers Squibb Company 3-Thia-4-arylquinolin-2-one potassium channel modulators
US7145013B2 (en) * 2003-10-14 2006-12-05 Bristol-Myers Squibb Company 3-thia-4-arylquinolin-2-one derivatives
US7002015B2 (en) * 2003-10-14 2006-02-21 Bristol-Myers Squibb Company 3-Thia-4-arylquinolin-2-one derivatives as smooth muscle relaxants
US7151180B2 (en) * 2003-10-14 2006-12-19 Bristol-Myers Squibb Company Potassium channel modulators
EP1850852A4 (de) * 2005-02-22 2009-11-18 Cedars Sinai Medical Center Verwendung von sildenafil, vardenafil und anderen 5-phosphodiesterase-hemmern zur erhöhung der durchlässigkeit der abnormalen blut-hirn-schranke
WO2006091769A1 (en) * 2005-02-24 2006-08-31 Janssen Pharmaceutica N.V. Novel quinoline derivatives as potassium ion channel openers
WO2021252681A1 (en) * 2020-06-10 2021-12-16 Ideaya Biosciences, Inc. Quinolinone derivatives as methionine adenosyltransferase 2a inhibitors

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3202661A (en) * 1962-11-27 1965-08-24 Hoffmann La Roche Substituted 3-amino 4-phenyl quinolones
US5200422A (en) * 1990-09-24 1993-04-06 Neurosearch A/S Benzimidazole derivatives, their preparation and use
NZ239540A (en) * 1990-09-24 1993-11-25 Neurosearch As 1-phenyl benzimidazole derivatives and medicaments
US5234947A (en) * 1991-11-07 1993-08-10 New York University Potassium channel activating compounds and methods of use thereof
US5565483A (en) * 1995-06-07 1996-10-15 Bristol-Myers Squibb Company 3-substituted oxindole derivatives as potassium channel modulators

Also Published As

Publication number Publication date
EP0942723A1 (de) 1999-09-22
EP0942723B1 (de) 2004-01-21
DE69727312T2 (de) 2004-11-18
US5922735A (en) 1999-07-13
ZA9710561B (en) 1999-05-24
CA2266605A1 (en) 1998-06-04
EP0942723A4 (de) 2002-05-15
AU716832B2 (en) 2000-03-09
ES2214644T3 (es) 2004-09-16
WO1998023273A1 (en) 1998-06-04
TW504504B (en) 2002-10-01
JP2002508740A (ja) 2002-03-19
ATE258054T1 (de) 2004-02-15
US5892045A (en) 1999-04-06
AR010306A1 (es) 2000-06-07
AU7408598A (en) 1998-06-22

Similar Documents

Publication Publication Date Title
ATE195515T1 (de) 3-substituierte oxindolderivate als kaliumkanalmodulatoren
DE69935245D1 (de) 3-substituierte-4-arylchinolin-2-on derivate als kaliumkanal- modulatoren
DE69727312D1 (de) 4-aryl-3-hydroxychinolin-2-on-derivate als modulatoren des ionenkanals
FI964298A0 (fi) Faestningsanordning foer baerbar apparat
BR9704713A (pt) Combinação estabilizadora
DE69712331D1 (de) Pyrimidin-4-on derivate als pestizidesmittel
PT934320E (pt) Derivados de naftiridina
DE59706144D1 (de) Ausrichtvorrichtung
BR9708386A (pt) Derivados de 6-fenilpiridil-2-amina
DE69732364D1 (de) Ionenquelle
DE69705112T2 (de) Coralynanaloge als topoisomerase inhibitoren
BR9710577A (pt) Composi-Æo de xampu
BR9709065A (pt) Derivados de alquilaminobenzotiazole e-benzoxazol
BR9609927A (pt) Estabilização de pigmentos
BR9703909A (pt) Formador de blocos
BR9705635A (pt) Compostos
DE59712835D1 (de) Stabilisierte monomerenzusammensetzung
PT923594E (pt) Compostos de bromotiacumicina
KR980000801U (ko) 경혈 지압구
PT931087E (pt) Novos derivados de piranosido
ID16838A (id) Komposisi dekafluoropentana
BR9704422A (pt) Composto de borracha contendo aminobenzilamina
PT906279E (pt) Derivados de pirrol
MD665F1 (ro) Rachiu Vodka
ID17345A (id) Metode yang disempurnakan untuk mengendalikan rayap

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee